Category: HPB & Spleen

Anesthetic Parameters in Hepatectomy with Inferior Vena Cava Clamping

The study aimed to analyze the hemodynamic and surgical effects of using the inferior vena cava (IVC) partial clamp (PC) in combination with the Trendelenburg position (TP) during anatomical hepatectomy. Twenty-six patients were divided into three groups based on the use of IVC-PC and TP. The results showed that IVC-PC combined with TP can be […]

Pancreatic Ductal Adenocarcinoma Resection: A 5.3-Year Journey to 95% Cure Probability

According to a multi-institutional analysis of 2554 patients, the probability of achieving the same life expectancy as the general population, with no tumor recurrence, after pancreatic surgery for pancreatic ductal adenocarcinoma (PDAC) was found to be 20.4%. Furthermore, the study revealed that the likelihood of cure reached 95% certainty after 5.3 years. Preoperative and postoperative […]

Novel Use of Falciform Ligament for MHV Reconstruction During Laparoscopic Hepatectomy of Colorectal Liver Metastasis

Reconstructing the major hepatic veins during laparoscopic hepatectomy for colorectal liver metastasis is challenging and requires complex techniques. This study presents a novel method of using the falciform ligament for MHV reconstruction, resulting in successful preservation of liver volume for adjuvant chemotherapy and prevention of venous congestion. The technique was found to be technically demanding […]

Improved Prognosis for Pancreatic Metastases from Renal Cell Carcinoma

A study evaluated the surgical pathology and outcomes of pancreatic metastases from renal cell carcinoma (RCC). The retrospective review included 25 patients who underwent pancreatic surgery, with 24 cases intended for cure. Postoperative complications occurred in 36% of patients, and one patient died during hospitalization. Recurrence was observed in 60% of patients, with a five-year […]

Identification of Non-Medical Barriers Affecting Surgical Attrition in Pancreatic Cancer

Researchers evaluated factors contributing to surgical attrition in non-metastatic pancreatic cancer. Clinical trials showed 25-30% of patients did not undergo surgery, mainly due to disease progression. The overall surgical rate in the national cancer database was 49%, increasing to 67% in a cohort resembling clinical trial patients. Low-volume institutions and uninsured or Medicaid-insured patients were […]

New Guidelines Provide Comprehensive Non-Surgical Treatment Approach for Hepatocellular Carcinoma

Italian scientific societies have collaborated to develop updated multidisciplinary treatment guidelines for hepatocellular carcinoma (HCC). The second part of these guidelines focuses on the non-surgical treatment options and the role of multidisciplinary tumor boards. The document, produced using evidence-based grading methodology, addresses the increasing complexity of HCC management and aims to assist clinicians and researchers […]

Comparable disease progression for small pancreatic neuroendocrine tumors (≤2 cm) with or without surgery

Researchers compared the disease progression in patients with nonfunctional pancreatic neuroendocrine tumors (pnets) ≤2 cm who either underwent surgery or were observed. Out of the 52 patients, 75% had an operation while 25% were observed. Both groups had similar demographics and tumor characteristics. The observation group had a mean disease progression interval of 80.9 months, […]

Residents with prior evaluations and feedback show improved performance and autonomy in common bile duct exploration

Surgical residents who receive prior evaluations and formative feedback for common bile duct exploration (CBDE) demonstrate better operative performance and greater autonomy compared to residents without prior evaluations. Cases with prior evaluations had a higher proportion of practice-ready or exceptional performance ratings according to both residents and attending surgeons. They also had a higher proportion […]

Optimizing Mortality Reduction in Necrotizing Pancreatitis

Researchers conducted a systematic review and network meta-analysis to determine the optimal timing and intervention for reducing mortality in necrotizing pancreatitis. They analyzed 10 studies involving 570 patients and compared 8 treatment strategies. While no statistically significant differences were found in odds ratios, trends were confirmed by the surface under the cumulative ranking scores. The […]